Skip to main content

Table 1 Infections sites in 97 children receiving ciprofloxacin

From: Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris

 

Community-acquired infection

Healthcare-associated infection

Nosocomial infection

Infection site

   

Broncho-pulmonary n (%)

5 (45.4)

17 (70.8)

24 (38.6)

Urinary tract n (%)

2 (18.2)

2 (8.3)

4 (6.5)

Bloodstream/catheter infection n (%)

0 (0)

0 (0)

2(3.2) /4 (6.5)

Infection of operative site n (%)

0 (0)

0 (0)

5 (8.2)

Bone or joint n (%)

2 (18.2)

0 (0)

2 (3.2)

Intra-abdominal n (%)

1 (9.1)

0 (0)

6 (9.7)

Mediastinal$ n (%)

0 (0)

0 (0)

3 (4.8)

Cerebral n (%)

1 (9.1)

1 (4.2)

2 (3.2)

Endocarditis n (%)

0 (0)

0 (0)

2 (3.2)

Others n (%)

0 (0)

4£ (16.7)

8§ (12.9)

Total n (%)

11 (100)

24 (100)

62 (100)

  1. £: 2 BCGitis and ocular infection and cutaneous infection each.
  2. §: Fever in 8 immunocompromised children among whom 4 with current neutropenia.
  3. Among 98 children who received ciprofloxacin, one received it as prophylaxis during orthopedic surgery (not shown in Table 1).
  4. $: Mediastinal infection means mediastinitis after cardiac or thoracic surgery.